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Background: Basolateral Kþ channels hyperpolarize colonocytes to ensure Naþ (and thus water) ab-
sorption. Small conductance basolateral (KCNQ1/KCNE3) Kþ channels have never been evaluated in
human colon. We therefore evaluated KCNQ1/KCNE3 channels in distal colonic crypts obtained from
normal and active ulcerative colitis (UC) patients.
Methods: KCNQ1 and KCNE3 mRNA levels were determined by qPCR, and KCNQ1/KCNE3 channel activity
in normal and UC crypts, and the effects of forskolin (activator of adenylate cyclase) and UC-related
proinﬂammatory cytokines on normal crypts, studied by patch clamp recording.
Results: Whereas KCNQ1 and KCNE3 mRNA expression was similar in normal and UC crypts, single 6.8 pS
channels were seen in 36% of basolateral patches in normal crypts, and to an even greater extent (74% of
patches, P < 0.001) in UC crypts, with two or more channels per patch. Channel activity was 10-fold
higher (P < 0.001) in UC crypts, with a greater contribution to basolateral conductance
(5.85 ± 0.62 mS cm2) than in controls (0.28 ± 0.04 mS cm2, P < 0.001). In control crypts, forskolin and
thromboxane A2 stimulated channel activity 30-fold and 10-fold respectively, while PGE2, IL-1b, and LTD4
had no effect.
Conclusions: KCNQ1/KCNE3 channels make only a small contribution to basolateral conductance in
normal colonic crypts, with increased channel activity in UC appearing insufﬁcient to prevent colonic cell
depolarization in this disease. This supports the proposal that defective Naþ absorption rather than
enhanced Cl secretion, is the dominant pathophysiological mechanism of diarrhea in UC.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Basolateral potassium (Kþ) channels play a central role in
maintaining colonic epithelial cells in a hyperpolarized state, which
is a critical requirement for ionic movements across the apical and
basolateral membranes. In healthy human colonic epithelium, the
basolateral Kþ conductance largely reﬂects intermediate conduc-
tance basolateral Kþ (IK; KCNN4) channels [1]. In active ulcerative
colitis (UC), the marked decrease in IK channel expression/activity
(with ensuing cellular depolarization) has been proposed as one of
the factors contributing to colonic malabsorption of Naþ (and thus
water) in this disease [1]. Indeed, diarrhea, the dominant symptom
in UC, largely reﬂects defective Naþ and water absorption, ratherLevel 7), St James's University
r Inc. This is an open access articlethan increased Cl secretion across the inﬂamed colonic mucosa
[2e5].
Although IK channels dominate the basolateral Kþ conductance
in human colon [1]. basolateral membranes of mouse small intes-
tinal and colonic crypt cells also contain small conductance Kþ (SK
or KCNQ1/KCNE3) channels [6e8]. However, the possible existence
of KCNQ1/KCNE3 channels and their contribution to the basolateral
Kþ conductance of human colonic crypt cells, has never been
explored. KCNQ1 is a Kþ channel protein with six transmembrane
domains, and interacts physically with the smaller b-subunit
KCNE3 protein, which has a single transmembrane domain [9].
KCNE3 changes the biophysical properties of KCNQ1, the KCNQ1/
KCNE3 complex forming a constitutively open basolateral Kþ
channel, which is present in mammalian small intestine and colon,
is readily stimulated by cAMP, markedly inhibited by chromanol
293B, and is a prerequisite for cAMP-stimulated electrogenic Cl
secretion, such as that triggered by a variety of intestinal pathogens
[9]. The role of KCNQ1/KCNE3 channels appears to be to maintainunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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basolateral NaþeKþe2Cl cotransporter, thus hyperpolarizing the
cell while stimulating basolateral Cl uptake as a prelude to apical
Cl exit via CFTR Cl channels [9]. However, the transmucosal
electrical properties of the colon in active UC are not consistent
with electrogenic Cl secretion [2,3], nor has Cl secretion been
reported in this disease in previous ion transport studies [2,10],
which raises the possibility that the expression/activity of putative
KCNQ1/KCNE3 channels in the inﬂamed colon might be decreased.
The aims of the present study were to identify and characterize
KCNQ1/KCNE3 channels in healthy (control) human colon, and then
study their activity in patients with active UC.
2. Materials and methods
2.1. Quantitative polymerase chain reaction (qPCR)
Crypts for qPCR were isolated from 5 to 6 sigmoid mucosal bi-
opsies taken during colonoscopic evaluation of patients with
functional abdominal pain who were free of inﬂammatory bowel
disease (controls, n ¼ 9), and patients with moderately active UC
(n ¼ 7), by Ca2þ chelation [11]. Crypts were pelleted by centrifu-
gation and total RNA extracted using TRI reagent (Sigma) according
to the manufacturer's instructions. RNA was quantiﬁed by a Ribo-
Green (Invitrogen, Paisley, UK) assay, using a standard curve con-
structed with RNA of known concentrations. 1 mg of total RNA was
reverse transcribed at 37 C using Superscript reverse transcriptase
(Invitrogen, Paisley, UK) with oligo-(dT)12e18 primers according to
the manufacturer's instructions.
cDNAwas subsequently used as a template for 40 rounds of PCR
with intron-spanning primers speciﬁc for human KCNQ1 (sense
AGCAGAAGCAGAGGCAGAAG; antisense CTGGGTGACAGCA-
GAGTGTG, KCNE3 (sense GCAGAGGGAAATGAGACAGG; antisense
CAGGGTGGTGGTGGTAAATC) and b-actin (sense AGAAAATCTGG-
CACCACACC; antisense GGGTGTTGAAGGTCTCAAA), the latter
acting as an endogenous reference to allow compensation for small
variations in sample concentration. Ampliﬁcation of DNA products
was measured in real-time (Lightcycler, Roche) by incorporating
the DNA-binding dye SYBR Green I (Quantitech). Primer efﬁcacy
was validated by gel electrophoresis of the PCR reaction, and
ampliﬁcation of single products of the expected molecular weight
(KCNQ1 160 bp; KCNE3 119 bp; b-actin 148 bp) conﬁrmed by
sequencing (Lark Technologies). Real-time PCR crossing point (Cp)
was determined using the ‘second derivative maximum method’
[12]. PCR efﬁciency (E) was calculated from the slope of the log-
linear ampliﬁcation phase using the LinReg software package
[13]. The amounts of KCNQ1 and KCNE3 mRNA relative to b-actin
were expressed as ECpb-actin/ECpchannel [14]. The speciﬁcity of
RTePCR products was also routinely conﬁrmed by melting curve
analysis.
2.2. Patch clamp recording
Crypts for patch clamp studies were isolated from colonoscopic
mucosal biopsies taken during evaluation of consented control
patients (n ¼ 34), and patients with moderately active UC (n ¼ 9),
by Ca2þ chelation [11]. None of the patients was receiving steroid
treatment. Crypts were maintained on ice until required. Crypts
were placed on a glass coverslip pre-treated with poly-L-lysine
(0.1%) in a perfusion chamber (Warner Instruments), which was
mounted on an inverted microscope (Nikon Diaphot). The perfu-
sion chamber solution contained 140mMNaCl, 4.5 mMKCl,1.2 mM
CaCl2, 1.2 mM MgCl2, 10 mM HEPES, and 5 mM glucose, titrated to
pH 7.4 with NaOH. Patch pipettes were fabricated from soda-lime
microhematocrit glass using a two-stage puller (Narishige, ModelPP-83) and had tip resistances of 2e4 MU when ﬁlled with a so-
lution containing 145 mM KCl, 1.2 mM CaCl2, 1.2 mMMgCl2, 10 mM
HEPES and 5 mM glucose, titrated to pH 7.4 with KOH. After ﬁlling
with solution, pipettes were subsequently dipped brieﬂy, up to the
base of the shank, in silane (Sigmacote, Sigma) to reduce stray
capacitance. Patch clamp recordings were obtained in the cell-
attached conﬁguration from the basolateral membranes of cells in
the mid-third region of crypts. Cell currents were ampliﬁed and
low-pass ﬁltered at 2 kHz (Axopatch 200B, Axon Instruments), and
sampled to computer at 5 kHz via a Digidata 1320A interface (Axon
Instruments). Command potentials (Vcom) were applied to the
pipette interior and referenced to the bath (ground). Data acquisi-
tion and analysis were performed using pClamp 9.0 software (Axon
Instruments). Channel activity was measured as N.Po, where Po is
the single channel open probability and N is the number of chan-
nels in the patch (taken to be the maximum number of open
channels during the recording).
Having identiﬁed basolateral KCNQ1/KCNE3 channels in crypts
from control patients, additional experiments were performed to
determine the effect of 10 mM forskolin (an activator of adenylate
cyclase, thereby increasing intracellular cAMP concentration), and a
variety of inﬂammatory mediators present at increased concen-
tration in the colonic epithelium of patients with active UC: 100 nM
prostaglandin E2 (PGE2), 1 mM thromboxane A2 (TXA2), 10 nM
interleukin 1-b (IL-1b), and 1 mM leukotriene D4 [15e18]. Re-
cordings of KCNQ1/KCNE3 channel activity were made before and
5 min after addition of the agent under study to the bath solution.
2.3. Statistics
Data are given as mean ± SEM, where n corresponds to the
number of subjects unless otherwise indicated. Comparison be-
tween groups was made using the Wilcoxon Signed Rank test and
ManneWhitney U test for paired and unpaired data, respectively.
3. Results
3.1. Molecular characteristics of KCNQ1/KCNE3 channels in human
colon
RT-PCR using speciﬁc primers indicated the presence of KCNQ1,
KCNE3 and b-actin (as the internal control) in colonic crypt cells
from control patients and those with active UC. Agarose gel (1.3%)
electrophoresis showed that the single product bands were of the
expected size (Fig. 1A), fragment sizes for KCNQ1, KCNE3 and b-
actin being 160 bp, 119 bp and 148 bp, respectively. The identity of
the products was conﬁrmed by automated sequencing (Lark Tech-
nologies). Ampliﬁcation of KCNQ1, KCNE3 and b-actin mRNAs was
monitored using SYBR Green 1, and during PCR ampliﬁcation, SYBR
green ﬂuorescence increased in a log-linear fashion once it was
above the threshold for detection by the lightcycler (Fig. 1B).
Speciﬁcity of the RT-PCR products was also conﬁrmed by melting
curve analysis, the rate of release of the ﬂuorophore during DNA
strand separation being greatest at the product-speciﬁc melting
temperature (Tm), the presence of a single peak indicating the
presence of a single product. Themeasured values of Tm for KCNQ1,
KCNE3 and b-actin were 85.1 C, 77.1 C and 85.2 C, respectively
(Fig. 1C). There were no signiﬁcant differences in the expression of
KCNQ1 mRNA or KCNE3 mRNA between control patients and those
with active UC (Fig. 1D).
3.2. Electrophysiological characteristics of KCNQ1/KCNE3 channels
in human colon
KCNQ1/KCNE3 channel activity was studied in cell-attached
Fig. 1. (A) Agarose gel showing RT-PCR products of KCNQ1 and KCNE3 in control human sigmoid colon. L ¼ 100 bp ladder, þve ¼ cDNA template present, -ve ¼ cDNA template
absent. (B) Plot of logarithmic ﬂuorescence versus RT-PCR cycle number, showing the log-linear phase of PCR ampliﬁcation. (C) Melting curve analysis of PCR products. (D) Relative
levels of KCNQ1 and KCNE3 mRNA in control and UC patients.
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gion of crypts obtained from control patients (n ¼ 34), channel
activity being observed in 36% of patches. Representative re-
cordings, together with the corresponding currentevoltage (I/Vcom)
relationship, are shown in Fig. 2A and B, respectively. Patches
usually contained one channel (Fig. 2A), with a slope conductance
of 6.8 ± 0.5 pS. This value was of the same order as those obtained
for the basolateral KCNQ1/KCNE3 channel in rat colon crypt cells
(~3 pS) [19], and the human KCNQ1/KCNE3 channel (4.5 pS)
expressed in Xenopus oocytes [20]. By contrast, KCNQ1/KCNE3
channel activity was observed in 74% of patches in crypts obtained
from patients with active UC (n ¼ 9), the difference in channel
prevalence between the two groups of patients being signiﬁcant
(P < 0.001). Furthermore, patches from UC patients usually con-
tained two or more channels (Fig. 3B), and overall KCNQ1/KCNE3
channel activity (N.Po) was 10-fold greater in UC patients
(1.13 ± 0.28) than in control patients (0.11 ± 0.02, P < 0.001).
The physiological importance of the basolateral Kþ conductance
of epithelial cells in general lies in its role in allowing Kþ ions to
recycle across the membrane, thus keeping cells hyperpolarized, a
prerequisite for vectorial ion transport. Based on the assumption
that IK channels account formost of the basolateral Kþ conductance
in normal human colonic crypt cells, we previously reported that
the decreases in basolateral IK channel expression and activity seen
in active UC lead to a ~75% decrease in basolateral Kþ conductance
[1]. In the present study, we calculated basolateral membrane
conductance due to KCNQ1/KCNE3 channels (GSK) in control and UC
patients as:GSK ¼ fraction of patches containing channels N:Po  g
with N.Po taken as the average N.Po of all patches obtained from
an individual patient rather than the N.Po of a single patch, a single
channel conductance (g) of 7 pS, and an assumed patch area of
1 mm2. The calculated value of GSK in patients with active UC
(5.85 ± 0.62 mS cm2) was signiﬁcantly greater than the value in
control patients (0.28 ± 0.04 mS cm2, P < 0.001).3.3. Activation of KCNQ1/KCNE3 channels in human colon
In cell-attached patches using crypts from control patients,
addition of 10 mM forskolin to the bath solution resulted in the
stimulation of basolateral KCNQ1/KCNE3 channels, N.Po increasing
from 0.01 ± 0.003 to 0.32 ± 0.08 (P < 0.005, n ¼ 8), and a repre-
sentative experiment is shown in Fig. 4A. The addition of 1 mMTXA2
also stimulated KCNQ1/KCNE3 channel activity, N.Po increasing
from 0.02 ± 0.01 to 0.18 ± 0.07 (P < 0.05, n ¼ 5), and a represen-
tative experiment is shown in Fig. 4B. However, neither 100 nM
PGE2, 10 nM IL-1b, nor 1 mM LTD4 had any signiﬁcant effect on
KCNQ1/KCNE3 channel activity (0.08 ± 0.05 versus 0.24 ± 0.19,
P ¼ 0.4, n ¼ 6; 0.12 ± 0.11 versus 0.28 ± 0.09, P ¼ 0.25, n ¼ 5; and
0.25 ± 0.18 versus 0.25 ± 0.08, P ¼ 0.99, n ¼ 4, respectively).4. Discussion
The present study shows for the ﬁrst time that (i) both KCNQ1
mRNA and KCNE3 mRNA are present in control human colonic
Fig. 2. (A) SK channel currents across a cell-attached basolateral membrane patch on a
crypt from control sigmoid colon at different command potentials (Vcom) referenced to
the pipette interior. Broken line indicates closed channel current and downward de-
ﬂections indicate channel openings. (B) Linear I/Vcom relationship of the SK channel
shown in A.
Fig. 3. SK channel currents across cell-attached basolateral membrane patches on
crypts from (A) control and (B) UC sigmoid colon, at a command potential (Vcom)
of 100 mV (referenced to pipette interior). Broken line indicates closed channel
current and downward deﬂections indicate channel openings.
Fig. 4. SK channel currents across cell-attached basolateral membrane patches on
crypts from normal sigmoid colon, in the basal state and after the addition of 10 mM
forskolin (A) or (B) 1 mM TXA2. Recordings were obtained at a command potential
(Vcom) of 100 mV (referenced to pipette interior), broken lines indicating closed
channel currents and downward deﬂections indicating channel openings.
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tivity are present in the basolateral membranes of these cells, and
(iii) these low basal levels of KCNQ1/KCNE3 channel activity are
markedly stimulated by forskolin-induced cAMP-dependent
phosphorylation. We found the single channel conductance of
basolateral KCNQ1/KCNE3 channels in control human colon
(6.8 ± 0.5 pS) to be similar to that of human KCNQ1/KCNE3 chan-
nels expressed in Xenopus oocytes (4.5 pS) [20]. Based on the
ﬁndings that basolateral KCNQ1/KCNE3 channels (i) co-exist with
apical Cl (CFTR) channels in intestinal crypt cells [21], (ii) are
stimulated by cAMP [8], and (iii) inhibited by chromanol 293B
(resulting in the inhibition of electrogenic Cl secretion) [8], it has
become clear that these Kþ channels play a critical role during
cAMP-activated Cl secretion, recycling Kþ ions across thebasolateral membrane to maintain a favourable electrical gradient
for apical Cl exit, thus making them a prime target for novel anti-
diarrheal drugs.
Although we observed an increase in basolateral KCNQ1/KCNE3
channel activity, and what appeared to be an increase in the
number (and presumably density) of channels per patch in cells
from UC patients compared with controls, the levels of KCNQ1
mRNA and KCNE3 mRNA were similar in the two groups. This
suggests that the apparent increase in KCNQ1/KCNE3 channel
density reﬂects a post-transcriptional event, possibly increased
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would be in broad agreement with our previous ﬁnding of uniform
expression of high conductance apical potassium (BK; KCNMA1)
channels along the entire surface-crypt cell axis in UC patients,
whereas they are largely restricted to surface cells and cells in the
upper 20% of crypts in control human colon [22]. Why KCNQ1/
KCNE3 channel expression (or for that matter BK channel expres-
sion) should be increased in human UC is unclear, but it is inter-
esting that butyrate, a key energy source for colonocytes,
suppresses NKCC1 (basolateral Naþ-Kþe2Cl cotransporter
isoform-1) gene expression in human colon-derived HT29 cells
[23]. Thus, it is conceivable that reduced oxidation of butyrate by
colonic epithelial cells, as occurs in UC [24], might result in upre-
gulation of KCNQ1/KCNE3 and/or BK channels in this disease. In any
event, our ﬁnding of increased basolateral KCNQ1/KCNE3 channel
activity in active UC is in marked contrast to our previously re-
ported observation of substantial decreases in basolateral IK
channel expression and activity in these patients [1]. We have
proposed that these changes may explain the cell depolarization
seen in active UC, thereby decreasing the electrical driving force for
electrogenic Naþ absorption (and as a consequence, Cl and water
absorption) across the inﬂamed mucosa [1]. Despite the fact that
the increase in basolateral KCNQ1/KCNE3 channel activity in UC
patients resulted in a signiﬁcantly greater calculated basolateral
membrane conductance (GSK, 5.85 ± 0.62 mS cm2) compared with
controls (0.28 ± 0.04 mS cm2, P < 0.001), this increase in GSK was
too small to fully compensate for the ~17 mS cm2 decrease in
basolateral membrane conductance secondary to reduced IK
channel expression and activity in UC patients [1]. Thus, while the
increase in basolateral KCNQ1/KCNE3 channel activity in UC pa-
tients could be construed as an attempt to maintain colonocytes in
a state of hyperpolarization, this clearly does not occur, as colo-
nocytes in UC patients have been shown to be signiﬁcantly depo-
larized in studies using intracellular microelectrodes [3].
Our studies using crypts from control patients showed that
increasing intracellular cAMP (using exogenous forskolin) elicited a
30-fold rise in basolateral KCNQ1/KCNE3 channel activity. This
observation is consistent with the chromanol 293B-inhibitable,
cAMP-stimulated Cl secretion previously demonstrated in mouse
colon [25], highlighting the channel's role in basolateral Kþ recy-
cling in order to maintain a favourable electrical gradient for apical
Cl exit. PGE2 is an eicosanoid inﬂammatory mediator produced in
leukocytes by the oxidation of arachidonic acid through arach-
idonate 5-lipoxygenase activity, and its intramucosal levels are
substantially increased in UC [16]. Since the ion transport effects of
PGE2 are at least partly mediated by cAMP [26,27], the higher levels
of KCNQ1/KCNE3 channel activity seen in UC patients may have
reﬂected a cAMP-dependent stimulatory effect of PGE2. However,
for reasons that are unclear, 100 nM PGE2 failed to activate KCNQ1/
KCNE3 channel activity in control crypts. We also studied the effect
of TXA2, another eicosanoid inﬂammatory mediator present at
increased concentrations in the inﬂamed colonic mucosa in active
UC, and capable of stimulating Cl secretion in normal rat colon
[16]. Unlike PGE2, TXA2 elicited a 10-fold increase in KCNQ1/KCNE3
channel activity in control crypts, which suggests a regulatory link
between TXA2 receptors and KCNQ1/KCNE3 channels. TxA2 has
been shown to increase intracellular Ca2þ in platelets [28], and thus
its stimulatory effect on KCNQ1/KCNE3 channels in human colonic
crypts may also be Ca2þ-mediated, since carbachol (a Ca2þ-medi-
ated cholinergic agonist) activated KCNQ1/KCNE3 channels during
its stimulation of Cl secretion in mouse colon [29]. Intracellular
Ca2þ regulates KCNQ1 via calmodulin and other Ca2þ-sensor pro-
teins [30]. Interestingly, the antidiarrheal drug loperamide mark-
edly inhibits TxA2-induced Cl secretion in normal rat distal colon
without affecting the TxA2-induced increase in intracellular Ca2þconcentration [31]. Furthermore, the speciﬁc calmodulin inhibitor
W-7 has an even greater inhibitory effect on TxA2-induced Cl
secretion, which suggests that loperamide's antisecretory effect
involves blockade of the calmodulin system [31]. However, even if
PGE2 and TXA2 stimulate KCNQ1/KCNE3 channel activity in active
UC, this is not accompanied by an overall Cl secretory response, as
net colonic Cl secretion does not occur in patients with this dis-
ease [2,3]. By contrast, the proinﬂammatory mediators IL-1b
(which originates from helper CD4 T lymphocytes, monocytes,
macrophages and endothelial cells), and LTD4 (another eicosanoid
inﬂammatory mediator), both of which stimulate Cl secretion in
non-inﬂamed mammalian colon [15,17], failed to stimulate KCNQ1/
KCNE3 channel activity in control crypts, due to either the acute
nature of our experiments, or the non-involvement of KCNQ1/
KCNE3 channels in the Cl-secretory effects of IL-1b and LTD4.
In summary, we have shown for the ﬁrst time that cAMP-
stimulated KCNQ1/KCNE3 channels reside in the basolateral
membrane of healthy human colonic crypt cells, and that their
activity is increased in active UC. This builds on our previous
studies, which indicated an expanded distribution of apical BK
channels, with the virtual disappearance of basolateral IK channels,
along the surface-crypt axis in these patients [1,22]. Thus, it is clear
that different types of Kþ channel, each with a crucial role to play in
ion transport across healthy human colon, undergo profound
changes in expression and activity in active UC. A more detailed
picture is therefore emerging about the pathophysiology of diar-
rhoea in this disease [1]. Given the recent evidence in human colon
for partitioning of Cl and Kþ secretory pathways between colo-
nocytes and goblet cells respectively [32], further studies are
required to map different types of Kþ channel along the surface-
crypt axis in healthy and inﬂamed colon, and to identify the
intracellular mechanisms that modify Kþ channel expression dur-
ing the inﬂammatory process.
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